Unproven Therapies Are ‘Muddying’ Cell and Gene Advances

February 26, 2019

(Medscape) – The revolutionary impact of novel cell and gene-based therapies that have recently been approved, many in oncology and hematology, is in danger of being muddied by a huge number of unproven therapies, which could ruin the field’s reputation, warn two leading experts. The world of cell and gene therapy is at a “crossroads,” commented John Rasko, MD, PhD, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia, speaking here at the Transplantation and Cellular Therapy (TCT) 2019.

Recommended Reading